Helicobacter pylori eradication shifts monocyte Fcγ receptor balance toward inhibitory FcγRIIB in immune thrombocytopenic purpura patients A Asahi, T Nishimoto, Y Okazaki, H Suzuki, T Masaoka, Y Kawakami, ... The Journal of clinical investigation 118 (8), 2939-2949, 2008 | 176 | 2008 |
CD4+ CD25+ Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia T Nishimoto, M Kuwana Seminars in hematology 50, S43-S49, 2013 | 139 | 2013 |
Critical role of CD4+ CD25+ regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia T Nishimoto, T Satoh, T Takeuchi, Y Ikeda, M Kuwana Experimental hematology 40 (4), 279-289, 2012 | 85 | 2012 |
PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population C Terao, K Ohmura, Y Kawaguchi, T Nishimoto, A Kawasaki, K Takehara, ... Arthritis & Rheumatism 65 (2), 472-480, 2013 | 73 | 2013 |
Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis XX Nguyen, T Nishimoto, T Takihara, L Mlakar, AD Bradshaw, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 320 (1 …, 2021 | 39 | 2021 |
Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia T Nishimoto, M Numajiri, H Nakazaki, Y Okazaki, M Kuwana International journal of hematology 100, 341-344, 2014 | 34 | 2014 |
Predominant autoantibody response to GPIb/IX in a regulatory T‐cell‐deficient mouse model for immune thrombocytopenia T Nishimoto, T Satoh, EK Simpson, H Ni, M Kuwana Journal of Thrombosis and Haemostasis 11 (2), 369-372, 2013 | 31 | 2013 |
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model T Nishimoto, L Mlakar, T Takihara, C Feghali-Bostwick International immunopharmacology 28 (2), 1102-1105, 2015 | 28 | 2015 |
Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis T Watanabe, T Nishimoto, L Mlakar, J Heywood, M Malaab, S Hoffman, ... PLoS One 12 (6), e0179917, 2017 | 24 | 2017 |
A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis T Nishimoto, N Seta, R Anan, T Yamamoto, Y Kaneko, T Takeuchi, ... Clin Exp Rheumatol 32 (2), 211-7, 2014 | 24 | 2014 |
IGFBP-5 promotes fibrosis independently of its translocation to the nucleus and its interaction with nucleolin and IGF Y Su, T Nishimoto, C Feghali-Bostwick PLoS One 10 (6), e0130546, 2015 | 22 | 2015 |
Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia T Satoh, K Miyazaki, A Shimohira, N Amano, Y Okazaki, T Nishimoto, ... Blood, The Journal of the American Society of Hematology 122 (11), 1991-1992, 2013 | 22 | 2013 |
A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus H Hanaoka, T Nishimoto, Y Okazaki, T Takeuchi, M Kuwana Arthritis Research & Therapy 22, 1-13, 2020 | 18 | 2020 |
Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis S Suzuki, T Nishimoto, M Kohno, K Utsugisawa, Y Nagane, M Kuwana, ... Journal of Neuroimmunology 258 (1-2), 61-66, 2013 | 18 | 2013 |
Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4 YY Su, T Nishimoto, S Hoffman, XX Nguyen, JM Pilewski, ... FASEB bioAdvances 1 (3), 167, 2019 | 16 | 2019 |
E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects S Sharma, T Watanabe, T Nishimoto, T Takihara, L Mlakar, XX Nguyen, ... JCI insight 6 (24), 2021 | 13 | 2021 |
Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors T Nishimoto, Y Okazaki, M Numajiri, M Kuwana International journal of hematology 105, 598-605, 2017 | 4 | 2017 |
Ameliorating fibrosis in murine and human tissues with END55, an Endostatin-derived fusion protein made in plants L Mlakar, SM Garrett, T Watanabe, M Sanderson, T Nishimoto, J Heywood, ... Biomedicines 10 (11), 2861, 2022 | 3 | 2022 |
Lysyl oxidase induces fibrosis via upregulation of IL-6 and serves as a biomarker to monitor response to therapy T Nishimoto, T Takihara, L Mlakar, J Heywood, A Bradshaw, ... A74. MATRIX: DRIVERS AND TARGETS, A2441-A2441, 2016 | 3 | 2016 |
Anti-Fibrotic Mechanisms of Endostatin-Derived Peptide Are the Result of Reduction in Pro-Fibrotic Mediators and Promotion of Extracellular Matrix Degradation T Watanabe, T Nishimoto, T Takihara, L Mlakar, Y Su, ... Arthritis & Rheumatology 69, 2017 | 1 | 2017 |